Category: Press Release - Page 75 - Psychedelic Alpha

Read more about the article Numinus Identified as a Licensed Psilocybin Supplier by Health Canada

Numinus Identified as a Licensed Psilocybin Supplier by Health Canada

Post published:January 27, 2022
Post category:Press Release

Read more about the article Nova Mentis and KGK Science Form Tactical Partnership

Nova Mentis and KGK Science Form Tactical Partnership

Post published:January 27, 2022
Post category:Press Release

Read more about the article atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments

atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments

Post published:January 27, 2022
Post category:Press Release

Read more about the article Filament Health Subsidiary Psilo Scientific Announces Inclusion in Health Canada List of Licensed Psilocybin Producers

Filament Health Subsidiary Psilo Scientific Announces Inclusion in Health Canada List of Licensed Psilocybin Producers

Post published:January 26, 2022
Post category:Press Release

Read more about the article Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada

Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada

Post published:January 26, 2022
Post category:Press Release

Read more about the article PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19

PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19

Post published:January 26, 2022
Post category:Press Release

Read more about the article Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions

Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions

Post published:January 26, 2022
Post category:Press Release

Read more about the article Numinus Wellness Inc. Graduates to the OTCQX Best Market

Numinus Wellness Inc. Graduates to the OTCQX Best Market

Post published:January 26, 2022
Post category:Press Release

Read more about the article MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

Post published:January 25, 2022
Post category:Press Release

Read more about the article Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014

Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014

Post published:January 25, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.